No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CR240719C145000
- 1.99
- -1.51-43.14%
15min DelayClose Jul 5 16:00 ET
1.99High1.75Low
1.75Open3.50Pre Close2 Volume502 Open Interest145.00Strike Price374.00Turnover25.13%IV2.91%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier14DDays to Expiry1.99Extrinsic Value100Contract SizeAmericanOptions Type0.4060Delta0.0549Gamma71.42Leverage Ratio-0.1065Theta0.0217Rho29.00Eff Leverage0.1090Vega
Intraday
- 5D
- Daily
News
Investors Aren't Buying China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Earnings
When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 29x, you may consider China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) as a highly attracti
Double-Crane Pharmaceutical Unit Gets China Nod for Influenza Drug
China's medical products administrator granted China Resources Double-Crane Pharmaceutical (SHA:600062) subsidiary Jingxi Shuanghe Pharmaceutical a drug registration certificate for its peramivir inje
Finland's Konecranes Buys Crane Service Business in Germany
Konecranes (KCR.HE) said Monday it acquired the service business of German crane system services company Dungs Kran- und Anlagentechnik. The transaction, which closed the same day, is intended to stre
Crane Insiders Sold US$2.7m Of Shares Suggesting Hesitancy
The fact that multiple Crane Company (NYSE:CR) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are b
CR Double-Crane Pharmaceutical Registers Antibiotic, Ulcer Medications in China
China Resources Double-Crane Pharmaceutical (SHA:600062) secured drug registrations for its antibiotic and ulcer medications in China. Levofloxacin tablets are mainly used to treat or prevent infectio
InventHelp Inventor Develops New Tag Line Release Apparatus (RSM-194)
PITTSBURGH, June 25, 2024 /PRNewswire/ -- "I'm a crane operator, and I wanted to create a wirelessly controlled release mechanism to allow a coiled-up tag line to be dropped once the crane has lifted
Comments
Insiders selling shares below current price and lack of purchases over the past year raises caution. Despite ownership, their selling activity suggests a lack of urgency to buy. However, company's earnings growth is positive.
Possible Bearish Signals With Crane Insiders Disposing Stock 2
Insiders selling shares below current price could indicate they believe shares are fully valued. Modest insider ownership suggests some alignment with other shareholders.
1
The growth in profits and high level of insider ownership in Crane makes it an appealing stock to keep an eye on. The alignment of goals between shareholders and management is seen as a positive sign.
Crane's dwindling capital base is worrisome. If this persists, the company may shrink, potentially hindering its multi-bagger status. Despite strong stock performance in the past five years, underlying trends must improve for sustained optimism.
Despite Crane's shrinking earnings, its P/E ratio remains steady. Share prices risk falling unless conditions improve. Investors hope for a business turnaround, but analysts are skeptical.
1
Read more